Alexandra General Hospital of Athens
About Alexandra General Hospital of Athens
The Alexandra General Hospital is a General hospital in central Athens, Greece. It was established in 1954, initially as a Maternity Hospital and later as a Maternity & Obstetrics - Gynecological Hospital. It is located at Vassilisis Sofias avenue in the center of Athens.
There are 350 beds in Alexandra General Hospital of Athens.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
7
Clinical Trials at Alexandra General Hospital of Athens
During the past decade, Alexandra General Hospital of Athens conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma
2017-10-27
2023-12-26
Active, not recruiting
522
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
2017-11-07
2025-12-22
Active, not recruiting
390
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab
2019-05-31
2023-01-10
Terminated
88
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
2021-10-14
2026-10-01
Recruiting
560
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
2022-10-13
2029-09-06
Recruiting
810
A Study to Compare Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) in Participants With Newly Diagnosed Multiple Myeloma
2022-10-25
2033-05-13
Recruiting
1,060
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
2023-03-29
2031-08-16
Recruiting
590
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Alexandra General Hospital of Athens
According to Clinical.Site data, the most researched conditions in "Alexandra General Hospital of Athens" are
"Multiple Myeloma" (4 trials), "Relapsed or Refractory Multiple Myeloma" (2 trials) and "Smoldering Multiple Myeloma" (1 trials). Many other conditions were trialed in "Alexandra General Hospital of Athens" in a lesser frequency.
Clinical Trials Intervention Types at Alexandra General Hospital of Athens
Most popular intervention types in "Alexandra General Hospital of Athens" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (4 trials), "Daratumumab" (3 trials), "Pomalidomide" (3 trials), "Teclistamab" (3 trials) and "Bortezomib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Alexandra General Hospital of Athens
The vast majority of trials in "Alexandra General Hospital of Athens" are
7 trials for "All" genders.
Clinical Trials Status at Alexandra General Hospital of Athens
Currently, there are NaN active trials in "Alexandra General Hospital of Athens".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Alexandra General Hospital of Athens,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Alexandra General Hospital of Athens, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".